Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse

Lilly

Status and phase: Completed; Phase 4

Conditions: Comorbid Alcohol Abuse; ADHD

Treatments: Drug: placebo; Drug: Atomoxetine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00190957

B4Z-MC-LYBY

7069

Details and patient eligibility

About

Atomoxetine Treatment of Adults with ADHD and Comorbid Alcohol Abuse

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

You must be at least 18 years old.

You must have a diagnosis of ADHD and a diagnosis of alcohol abuse or dependence.

You must have acceptable results on blood and urine tests and an electrocardiogram (ECG).

Your recent drinking history must meet specific requirements.

Exclusion criteria

You have taken atomoxetine in the past.

You have a psychiatric disorder, other than ADHD and alcohol abuse or dependence, for which you will need psychiatric medication.

You have cognitive impairment (such as memory loss), a brain injury, or a seizure disorder.

You have a history of severe allergies to more than 1 class of medication or multiple bad reaction to drugs.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind